昊海生物科技11月11日斥资176.41万港元回购6.3万股

Core Viewpoint - Haohai Biological Technology (06826) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company plans to repurchase 63,000 shares at a total cost of HKD 1.7641 million [1] - The buyback is scheduled for November 11, 2025, which reflects a strategic move to enhance shareholder value [1]